James Garrett serves as our senior vice president, government and regulations strategy, and is responsible for designing and executing non-market (i.e., social, political and legal) strategies to assess opportunities and threats that may impact the Company’s business results, and for leading key global initiatives (e.g., compliance with the EU Medical Device Regulation).
Mr. Garrett’s prior role at NuVasive was leader of business and quality systems, responsible for global risk and integrity, regulatory affairs, quality affairs, information technology, and environmental health and safety. He has also served as NuVasive’s chief risk and compliance officer, and associate general counsel. Before joining the Company, he served as Counsel at DLA Piper where he focused on business, securities and corporate litigation. Mr. Garrett received his bachelor’s degree from the University of California, Los Angeles, and law degree from the University of San Diego School of Law.
NuVasive is committed to transform surgery, advance care and change lives through less invasive, procedurally integrated solutions. Since our inception in 1999, we continue to outperform the market as the largest, spine focused company in the world. With more than $1 billion in revenues, NuVasive has approximately 2,600 employees and operates in more than 50 countries serving surgeons, hospitals and patients.
Our employees directly influence our growth and innovation, significantly contribute to the success of the company, and actively support our vision. With a focus on building meaningful career experiences for our employees, our investment in diversity and inclusion, our commitment to supporting under-resourced communities around the globe with the NuVasive Spine Foundation, and our support of patients with The Better Way Back, we are passionate about helping our employees have purpose and most importantly—thrive!
